How would you manage a nodal recurrence of cutaneous SCC if the patient is unable to receive surgery for 6-8 weeks?
In a patient who would be otherwise fit for surgery +/- adjuvant RT, and the delay is caused by COVID-related OR staffing issues, what would be your approach?
Would your treatment approach differ depending on adverse features (i.e., ECE, high grade, etc)?
Community PollStarted
What is your management strategy for a nodal recurrence of cutaneous SCC if surgery will be delayed beyond >6 weeks?
52 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · Memorial Sloan Kettering Cancer Center
Answered on
I’d first consider referring the patient to a center that could perform the operation, as it is standard of care for a patient with resectable cSCC with nodal metastases.
At some centers, there may be a clinical trial of neoadjuvant immunotherapy that could be considered.
If those options were not...
Join for free or sign in to see the full answer